|
Mobile version
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
New blood test reveals fetus' gender 5 weeks after conception OBGYN.net (free registration required) Share    
A new blood test may safely reveal the gender of a fetus in the first trimester, according to new research. Researchers from KwanDong University College of Medicine in Seoul, South Korea, collected maternal plasma samples from 203 women who were between five weeks and 12 weeks gestation. Using quantitative methylation-specific polymerase chain reaction of the unmethylated-PDE9A gene, the researchers confirmed the presence of circulating fetal DNA. The researchers simultaneously quantified the amount of DYS-14, the Y-chromosome-specific sequence, and glyceraldehyde-3-phosphate dehydrogenase in maternal plasma. Phenotypes were confirmed at birth. More
Minimally invasive technique gets rid of potentially lethal blood clots in the brain News-Medical.net Share
Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull. The minimally invasive treatment increased by 10-15 percent the number of patients with intracerebral hemorrhage who could function independently six months following the procedure. More Mini, crablike robot removes stomach cancer medGadget Share
Researchers have developed a small robot designed to remove stomach cancer in its early stages. The minirobot resembles a crab, because it incorporates a pincer and a hook to do the job. The robot is mounted on an endoscope which reaches the stomach via the patient's mouth. The crablike robot has a pincer to grab the tissue to be removed, and the hook can cut the tissue and cauterize it to stop the bleeding. More
Diabetes drugs tied to pancreatic cancer risk Reuters Share
A new study links the diabetes drug metformin to fewer cases of pancreatic cancer — at least in women — but finds other diabetes medications are associated with a higher risk of the disease. The differences in medication history among people who did or didn't get pancreatic cancer were small, researchers said, and it's unclear why the drugs might affect cancer risks in men and women differently. Still, the new finding is in line with previous research suggesting that metformin may decrease the risk of multiple cancers. More Heartburn drugs linked to hip fractures in women WebMD via CBS News Share
Postmenopausal women with a history of smoking who take heartburn drugs called proton pump inhibitors for two years or longer may be more likely to sustain a hip fracture. And the longer women take PPIs, the greater their risk. That said, the risk does disappear after women stop taking these drugs for two years, according to new findings in the journal BMJ. More
Morning-after pill may be new option to treat fibroids HealthDay News via DoctorsLounge Share
The morning-after pill may help shrink painful fibroids and relieve excessive bleeding, new research indicates. Two new studies suggest that the morning-after pill Ella (ulipristal) works just as well as Lupron in treating fibroid-linked uterine bleeding, with less risk of hot flashes. The drug lowers levels of the hormone progesterone, which feeds fibroids. More Partial mastectomy often followed by 2nd surgery Los Angeles Times Share
A partial mastectomy allows doctors to remove a cancerous tumor without having to remove the entire breast. However, a new study shows that 1 in 4 women who undergo a partial mastectomy have to return for another surgery to remove additional tissue. The study points to a long-standing problem in breast cancer treatment: There is no agreement among surgeons on how much healthy surrounding tissue to take out when removing a tumor. More effort should be made to better define "the appropriate distance required for a clear margin to be deemed adequate," the authors said. More
Study: How informed should your patients be? General Surgery News Share
Should surgeons disclose their volumes and outcomes during the informed consent process? For years, it's been a question hotly debated by surgeons, patients and jurists. Legally, there's no resolution on the matter. But a recent survey suggests that surgeons do have an ethical obligation to disclose information about their experience during informed consent discussions. And, the disclosure may one day be legally mandated in some jurisdictions. More ICD-10 conversion: Do or die InformationWeek Share
While most providers are busy deploying financial, technology and people resources to meet the meaningful use program requirements in the hope of obtaining large government bonuses, these payments are a drop in the bucket compared to the revenue your organization could lose if you miss the ICD-10 conversion deadlines. To put it bluntly, ignoring the Oct. 1, 2013, deadline could mean zero payments coming in for patient care. More |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
